Reduction in metabolite transverse relaxation times in amyotrophic lateral sclerosis
Abstract
Background: Proton magnetic resonance spectroscopy (1H MRS) is used frequently to evaluate normal and pathological states in brain. MRS results are often reported as ratios of peak areas from spectra acquired at a single echo time, primarily for the peaks arising from N-acetyl groups (NA), creatine/phosphocreatine (t-Cr), and choline (Cho). Peak areas, however, are affected not only by metabolite concentration, but also by transverse relaxation times (T2). While the ratio approach appears to be valid in normal brain, pathology may affect T2, thereby leading to misinterpretation of the apparent changes in metabolite ratios. The objective of the present study was to determine if any T2 changes might affect the apparent metabolite ratio measures, which we have previously reported as being abnormal in amyotrophic lateral sclerosis (ALS). Methods: 1H MRS data were acquired from the brainstems of ALS and control subjects, for a range of TE times, to calculate T2 times for each of NA, t-Cr, and Cho. Metabolite ratios were measured experimentally at TE=120 ms and calculated for TE=0 ms, based on measured T2 values. Results: The T2's for the ALS vs. control group were NA=272±10 ms vs. 351±58 ms (p<0.01), t-Cr=132±17 vs. 184±42 ms (p<0.02), and Cho=223±55 vs. 245±50 ms (p>0.05). The effect of these T2 changes on metabolite ratios showed both the NA/t-Cr (ALS=0.98±0.13, Control=1.44±0.10, p<0001) and Cho/t-Cr (ALS=1.01±0.12, Control=1.34±0.24, p<0.001) ratios to differ significantly between groups. Conclusion: This study confirms the presence of significant abnormalities in metabolite concentration in ALS brainstem and the importance of evaluating the effects of metabolite T2 values when making ratio measurements in disease states.
Keywords: Amyotrophic lateral sclerosis, Magnetic resonance spectroscopy, Metabolite T2, N-acetylaspartate, Creatine, Choline
To access this article, please choose from the options below
PII: S0022-510X(02)00074-6
© 2002 Elsevier Science B.V. All rights reserved.
